IL2 and progressive multifocal leukoencephalopathy: To increase HPyV-2-specific T-cells to treat the PML, he was then treated with recombinant IL-2; 500,000 units of IL-2 subcutaneously on Day 1 followed by 1,000,000 units daily thereafter.